Monographs: Dosage forms: Specific monographs: Benzylpenicillin potassium for injection (Benzylpenicillini kalici ad injectionem)

Description. A white or almost white, crystalline powder.

Category. Antibacterial drug.

Storage. Unless otherwise recommended by the manufacturer, the reconstituted solution should be used within 24 hours when stored at a temperature not exceeding 20 °C or within 7 days (14 days if a buffering agent is present) when stored at a temperature between 2 and 8 °C.

Labelling. The designation on the container should state the nature of the buffering agent. Expiry date.

Additional information. Strength in the current WHO Model list of essential medicines: 600 mg and 3 g of Benzylpenicillin.

Requirements

The powder for injections and the reconstituted solution for injections comply with the monograph for "Parenteral preparations".

Definition. Benzylpenicillin potassium powder for injections is a sterile powder of benzylpenicillin potassium. Benzylpenicillin potassium powder for injections usually contains a suitable buffering agent. The powder is sterilized by a suitable method (see 5.8 Methods of sterilization).

The container of Benzylpenicillin potassium powder for injections contains not less than 90.0% and not more than 110.0% of the amount of C16H17KN2O4S stated on the label.

Identity tests

• Either tests A and D or tests B, C, and D may be applied.

A. Carry out the examination as described under 1.7 Spectrophotometry in the infrared region. The infrared absorption spectrum is concordant with the spectrum obtained from benzylpenicillin potassium RS or with the reference spectrum of benzylpenicillin potassium.

B. Dissolve a quantity of the powder for injections equivalent to 0.1 g of Benzylpenicillin potassium in sufficient phosphate buffer, pH 7.0, (0.067 mol/l) TS to produce 100 mL. Dilute 10 mL with the same reagent to produce 100 mL (solution A). To 10 mL of solution A add 0.5 mL of a solution prepared by diluting 1 mL of penicillinase TS to 10 mL with water and allow to stand at 30 °C for 10 minutes (solution B). Place 5 mL of each of solutions A and B in two separate test-tubes and add to each tube 10 mL of acetate buffer, pH 4.6, TS and 5 mL of iodine (0.0005 mol/l) VS. After mixing the contents of each tube add 0.1 mL of starch TS; the mixture obtained with solution A is blue and that with solution B remains colourless.

C. To a quantity of the powder for injections equivalent to 2 mg of Benzylpenicillin potassium in a test-tube add 1 drop of water followed by 2 mL of sulfuric acid (~1760 g/l) TS and mix; the solution is colourless. Immerse the test-tube for 1 minute in a water-bath; the solution remains colourless. Place a further similar quantity of the powder for injections in a second test-tube, add 1 drop of water and 2 mL of formaldehyde/sulfuric acid TS, and mix; the solution is brownish yellow. Immerse the test-tube for 1 minute in a water-bath; a reddish brown colour is produced.

D. Ignite a small quantity of the powder for injections, dissolve the residue in water, and filter; on addition of 2 mL of sodium hydroxide (~80 g/l) TS to the filtrate it yields the reaction described under 2.1 General identification tests as characteristic of potassium.

Clarity and colour of solution. A solution of the powder for injections equivalent to 0.2 g of Benzylpenicillin potassium in 10 mL of carbon-dioxide-free water R is clear and colourless. (Keep this solution for the "pH value".)

Loss on drying. Dry the powder for injections to constant mass at 105 °C; it loses not more than 10 mg/g.

pH value. pH of the solution prepared above for the test of clarity and colour, 5.5-7.5.

Assay

Mix the contents of 10 containers and carry out the assay as described.

Dissolve a quantity of the powder equivalent to about 50 mg of Benzylpenicillin potassium, accurately weighed, in sufficient water to produce 1000 mL. Transfer two 2-mL aliquots of this solution into separate stoppered tubes. To one tube add 10 mL of imidazole/mercuric chloride TS, mix, stopper the tube, and place in a water-bath at 60 °C for exactly 25 minutes. Cool the tube rapidly to 20 °C (solution A). To the second tube add 10 mL of water and mix (solution B).

Without delay measure the absorbance of a 1-cm layer at the maximum at about 325 nm against a solvent cell containing a mixture of 2 mL of water and 10 mL of imidazole/mercuric chloride TS for solution A and water for solution B.

From the difference between the absorbance of solution A and that of solution B, calculate the amount of C16H17KN2O4S in the powder for injections by comparison with benzylpenicillin sodium RS similarly and concurrently examined, taking into account that each mg of benzylpenicillin sodium RS (C16H17N2NaO4S) is equivalent to 1.045 mg of benzylpenicillin potassium (C16H17KN2O4S). In an adequately calibrated spectrophotometer the absorbance of the reference solution should be 0.62 ± 0.03.

Bacterial endotoxins. Carry out the test as described under 3.4 Test for bacterial endotoxins; contains not more than 0.01 IU of endotoxin RS per mg of benzylpenicillin.

to previous sectionto next section